BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 2421885)

  • 1. Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs.
    Russo A; DeGraff W; Friedman N; Mitchell JB
    Cancer Res; 1986 Jun; 46(6):2845-8. PubMed ID: 2421885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo selective modulation of tissue glutathione in a rat mammary carcinoma model.
    Baruchel S; Wang T; Farah R; Jamali M; Batist G
    Biochem Pharmacol; 1995 Oct; 50(9):1505-8. PubMed ID: 7503802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
    Kramer RA; Greene K; Ahmad S; Vistica DT
    Cancer Res; 1987 Mar; 47(6):1593-7. PubMed ID: 3815359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitization effect of L-2-oxothiazolidine-4-carboxylate on tumor cells to melphalan and the role of 5-oxo-L-prolinase in glutathione modulation in tumor cells.
    Chen X; Batist G
    Biochem Pharmacol; 1998 Sep; 56(6):743-9. PubMed ID: 9751079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of glutathione in the in vitro synergism between 4-hydroperoxy-cyclophosphamide and cisplatin in leukemia cell lines.
    Peters RH; Jollow DJ; Stuart RK
    Cancer Res; 1991 May; 51(10):2536-41. PubMed ID: 2021933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of modulators of glutathione synthesis on the hepatotoxicity of 2-methylfuran.
    Ravindranath V; Boyd MR
    Biochem Pharmacol; 1991 May; 41(9):1311-8. PubMed ID: 2018563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of intracellular glutathione in induction of apoptosis by cisplatin in a human pharyngeal carcinoma cell line.
    Sugimoto C; Matsukawa S; Fujieda S; Noda I; Tanaka N; Tsuzuki H; Saito H
    Anticancer Res; 1996; 16(2):675-80. PubMed ID: 8687113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
    Liebmann JE; Hahn SM; Cook JA; Lipschultz C; Mitchell JB; Kaufman DC
    Cancer Res; 1993 May; 53(9):2066-70. PubMed ID: 8097674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cellular glutathione and glutathione S-transferase in the expression of alkylating agent cytotoxicity in human breast cancer cells.
    Chen G; Waxman DJ
    Biochem Pharmacol; 1994 Mar; 47(6):1079-87. PubMed ID: 8147907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation response of Chinese hamster cells after elevation of intracellular glutathione levels.
    Russo A; Mitchell JB
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1243-7. PubMed ID: 6469745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines.
    Mistry P; Loh SY; Kelland LR; Harrap KR
    Int J Cancer; 1993 Nov; 55(5):848-56. PubMed ID: 8244583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds.
    Meijer C; Mulder NH; Timmer-Bosscha H; Sluiter WJ; Meersma GJ; de Vries EG
    Cancer Res; 1992 Dec; 52(24):6885-9. PubMed ID: 1458477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral L-2-oxo-4-thiazolidine reduces bacterial translocation after radiation in the Fischer rat.
    Blair SL; Rose DM; Sachar S; Burt ME
    J Surg Res; 1996 Oct; 65(2):165-8. PubMed ID: 8903464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular glutathione depletion by diethyl maleate or buthionine sulfoximine: no effect of glutathione depletion on the oxygen enhancement ratio.
    Mitchell JB; Russo A; Biaglow JE; McPherson S
    Radiat Res; 1983 Nov; 96(2):422-8. PubMed ID: 6647769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roles of intracellular glutathione in antineoplastic chemotherapy.
    Russo A; Carmichael J; Friedman N; DeGraff W; Tochner Z; Glatstein E; Mitchell JB
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1347-54. PubMed ID: 3531114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of bleomycin cytotoxicity by glutathione depletion or elevation.
    Russo A; Mitchell JB; McPherson S; Friedman N
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1675-8. PubMed ID: 6207156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of glutathione depletion by buthionine sulfoximine on the sensitivity of EMT6/SF cells to chemotherapy agents or X radiation.
    Shrieve DC; Harris JW
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1171-4. PubMed ID: 3744936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione.
    Ozols RF; Louie KG; Plowman J; Behrens BC; Fine RL; Dykes D; Hamilton TC
    Biochem Pharmacol; 1987 Jan; 36(1):147-53. PubMed ID: 3801051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic effects of glutathione synthesis inhibition by L-buthionine-(SR)-sulfoximine on human and murine tumor cells.
    Dorr RT; Liddil JD; Soble MJ
    Invest New Drugs; 1986; 4(4):305-13. PubMed ID: 3583642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of SR 2508 sensitization in hypoxic V79 cells by manipulation of glutathione levels.
    Phillips TL; Mitchell JB; DeGraff WG; Russo A; Albright N; Rajpal R
    Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1335-9. PubMed ID: 2523886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.